Varian Medical Systems (VAR) & Its Rivals Head-To-Head Survey

Varian Medical Systems (NYSE: VAR) is one of 77 public companies in the “Advanced Medical Equipment & Technology” industry, but how does it weigh in compared to its competitors? We will compare Varian Medical Systems to related businesses based on the strength of its profitability, risk, earnings, dividends, analyst recommendations, institutional ownership and valuation.

Profitability

This table compares Varian Medical Systems and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Varian Medical Systems 8.85% 23.68% 10.74%
Varian Medical Systems Competitors -316.94% -24.41% -9.70%

Institutional & Insider Ownership

99.2% of Varian Medical Systems shares are held by institutional investors. Comparatively, 50.2% of shares of all “Advanced Medical Equipment & Technology” companies are held by institutional investors. 0.9% of Varian Medical Systems shares are held by company insiders. Comparatively, 18.4% of shares of all “Advanced Medical Equipment & Technology” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Risk & Volatility

Varian Medical Systems has a beta of 0.65, meaning that its share price is 35% less volatile than the S&P 500. Comparatively, Varian Medical Systems’ competitors have a beta of 1.27, meaning that their average share price is 27% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings for Varian Medical Systems and its competitors, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Varian Medical Systems 2 7 1 0 1.90
Varian Medical Systems Competitors 271 1867 3336 105 2.59

Varian Medical Systems presently has a consensus target price of $97.83, suggesting a potential downside of 10.07%. As a group, “Advanced Medical Equipment & Technology” companies have a potential downside of 9.15%. Given Varian Medical Systems’ competitors stronger consensus rating and higher probable upside, analysts clearly believe Varian Medical Systems has less favorable growth aspects than its competitors.

Valuation and Earnings

This table compares Varian Medical Systems and its competitors top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue NetIncome Price/Earnings Ratio
Varian Medical Systems $2.67 billion $249.60 million 40.44
Varian Medical Systems Competitors $2.14 billion $229.91 million -29.00

Varian Medical Systems has higher revenue and earnings than its competitors. Varian Medical Systems is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Summary

Varian Medical Systems beats its competitors on 7 of the 13 factors compared.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company also has Varian Particle Therapy (VPT) and the operations of the Ginzton Technology Center (GTC). Its VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer. Its ProBeam system is capable of delivering intensity modulated proton therapy (IMPT) using pencil beam scanning technology. Its ProBeam Compact is a single room proton therapy product.

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply